🇺🇸 FDA
Patent

US 8227661

Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions

granted A61KA61K47/6843A61K47/6913

Quick answer

US patent 8227661 (Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions) held by Lexicon Genetics, Inc. expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lexicon Genetics, Inc.
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K47/6843, A61K47/6913, A61K49/0008, A61K51/1018